Innovative 3D Models MatTek’s leadership in developing human-derived 3D tissue models such as skin, ocular, and respiratory tissues offers significant opportunities for partners seeking more reliable, human-relevant testing methods, especially in regulated industries like cosmetics, chemicals, and pharmaceuticals.

Global Presence & Distribution With tissue production facilities across the U.S., Europe, and China, MatTek enables quick and cost-effective access to advanced tissue models worldwide, making it an ideal partner for companies aiming to expand their in vitro testing capabilities internationally.

Recent Product Launches The launch of groundbreaking products like the EpiLiver tissue model and ultra low attachment spheroid plates indicates continuous innovation, providing sales opportunities for companies interested in cutting-edge biotechnologies for toxicity testing and tissue culture applications.

Research Collaborations Partnerships with organizations like Charles River Laboratories and participation in industry events position MatTek as a valuable collaborator for research institutions and biotech firms seeking to advance alternative testing methods and tissue engineering solutions.

Financial Growth & Acquisition Recent acquisition by Sartorius for $80 million, along with steady revenue in the $10-25 million range, signals strong market confidence and potential for expansion into new markets or product lines, inviting engagement with prospective collaborators or clients interested in innovative bioengineering solutions.